Seer, Inc.
SEER
Seer, Inc., a life sciences company, engages in developing and commercializing products to decode the secrets of the proteome. It develops Proteograph Product Suite, an integrated solution that comprises consumables, an automation instrumentation, and software that allows researchers to conduct proteomic studies in therapeutic and diagnostic research, and clinical trials. The company intends to seā¦ read more
Healthcare
Biotechnology
5 years
USD
Exclusive to Premium users
Price
per share adjusted in USD$1.85
Price+0.82%
$0.02
1Y
Price
Market Cap
$102.937m
Small
Price/Earnings 3y Avg5y Avg
-
Premium
Premium
Financial Reports
Key metrics over the past few years and other important metrics. Amounts in USD.-371.0%
EBITDA Margin-442.5%
Net Profit Margin-190.5%
Free Cash Flow Margin-371.0%
EBITDA Margin-442.5%
Net Profit Margin-190.5%
Free Cash Flow MarginRevenue
$16.326m
+17.1%
1y CAGR+4.1%
3y CAGR+35.5%
5y CAGREarnings
-$79.348m
+8.4%
1y CAGR+5.1%
3y CAGR-3.9%
5y CAGREPS
-$1.34
+3.6%
1y CAGR+1.9%
3y CAGR-5.0%
5y CAGRBook Value
$271.814m
$308.608m
Assets$36.794m
Liabilities$24.249m
DebtDebt to Assets
7.9%
-0.3x
Debt to EBITDAFree Cash Flow
-$46.067m
+7.3%
1y CAGR+13.0%
3y CAGR+1.4%
5y CAGRNo items found.
Press Releases
Statements and updates from the company